Centogene B V (CNTG)
$0.10 -$0.01 (-11.22%) 4:38 PM 12/11/24
NASDAQ | $USD | Diagnostics & ResearchStock Data
-
Market Cap
$9.43M -
Day's Range
$0.09 - $0.10 -
Volume
- -
52 Week Low / High
$0.04 - $1.28 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
CNTG's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 0
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $1.51
- Target Price
Company News
-
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease — May 14th, 2024
Centogene NV CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical research Companies amend existing drug discovery partnership for Evotec to lead continued development. Upon Evotec exercising its option, CENTOGENE to receive an option e...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$